{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:45:50Z","timestamp":1789706750093,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"am","delay-in-days":246,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006377","name":"Purdue University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG062435"],"award-info":[{"award-number":["R01AG062435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG060731"],"award-info":[{"award-number":["R01AG060731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AG57274"],"award-info":[{"award-number":["R44AG57274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG014449"],"award-info":[{"award-number":["P01AG014449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS121826"],"award-info":[{"award-number":["NS121826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG070447-01A1"],"award-info":[{"award-number":["R21AG070447-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["R01AG060731"],"award-info":[{"award-number":["R01AG060731"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["P01AG014449"],"award-info":[{"award-number":["P01AG014449"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["R44AG57274"],"award-info":[{"award-number":["R44AG57274"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["R01AG062435"],"award-info":[{"award-number":["R01AG062435"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["730313"],"award-info":[{"award-number":["730313"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.molstruc.2022.133574","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T20:24:05Z","timestamp":1655929445000},"page":"133574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Anti-fibrillization effects of sulfonamide derivatives on \u03b1-synuclein and hyperphosphorylated tau isoform 1N4R"],"prefix":"10.1016","volume":"1267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-9360","authenticated-orcid":false,"given":"Jessica S.","family":"Fortin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-3571","authenticated-orcid":false,"given":"Kazuma","family":"Shimanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Prasanth","family":"Saraswati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Tien","family":"Hagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susantha K.","family":"Ganegamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-9763","authenticated-orcid":false,"given":"Scott E.","family":"Counts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Borhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-0107","authenticated-orcid":false,"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hao","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.molstruc.2022.133574_bib0001","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.molstruc.2022.133574_bib0002","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","article-title":"Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.molstruc.2022.133574_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.molstruc.2022.133574_bib0004","first-page":"367","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.molstruc.2022.133574_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"16","key":"10.1016\/j.molstruc.2022.133574_bib0006","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","article-title":"Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation","volume":"288","author":"Crowe","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.molstruc.2022.133574_bib0007","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1074\/jbc.M410984200","article-title":"Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells","volume":"280","author":"Pickhardt","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.molstruc.2022.133574_bib0008","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1021\/bi700878g","article-title":"Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells","volume":"46","author":"Pickhardt","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.molstruc.2022.133574_bib0009","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1038\/ncomms10216","article-title":"Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups","volume":"6","author":"Soeda","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molstruc.2022.133574_bib0010","doi-asserted-by":"crossref","first-page":"i4474","DOI":"10.1136\/bmj.i4474","article-title":"No \"breakthrough\" in Alzheimer's disease","volume":"354","author":"Wise","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.molstruc.2022.133574_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2019.00034","article-title":"Pathological tau from Alzheimer's brain induces site-specific hyperphosphorylation and SDS- and reducing agent-resistant aggregation of tau in vivo","volume":"11","author":"Miao","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.molstruc.2022.133574_bib0012","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1016\/S0021-9258(18)32333-0","article-title":"Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments","volume":"258","author":"Selden","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.molstruc.2022.133574_bib0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.molstruc.2022.133574_bib0014","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"95","key":"10.1016\/j.molstruc.2022.133574_bib0015","first-page":"e51537","article-title":"In vitro aggregation assays using hyperphosphorylated tau protein","author":"Sui","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.molstruc.2022.133574_bib0016","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/mcp.O114.044412","article-title":"Protein interaction module-assisted function X (PIMAX) approach to producing challenging proteins including hyperphosphorylated tau and active CDK5\/p25 kinase complex","volume":"14","author":"Sui","year":"2015","journal-title":"Mol. Cell Proteomics"},{"issue":"11","key":"10.1016\/j.molstruc.2022.133574_bib0017","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","article-title":"Hyperphosphorylation renders tau prone to aggregate and to cause cell death","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.molstruc.2022.133574_bib0018","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1038\/s41598-020-73680-2","article-title":"Hyperphosphoryalted tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer\u2019s disease and cognitive functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molstruc.2022.133574_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-2-12","article-title":"Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology","volume":"2","author":"Rankin","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.molstruc.2022.133574_bib0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/acschembio.9b00325","article-title":"Major differences between the self-assembly and seeding behavior of heparin-induced and in vitro phosphorylated tau and their modulation by potential inhibitors","volume":"14","author":"Despres","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.molstruc.2022.133574_bib0021","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1074\/jbc.M114.589309","article-title":"Conformation determines the seeding potencies of native and recombinant Tau aggregates","volume":"290","author":"Falcon","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.molstruc.2022.133574_bib0022","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1074\/jbc.RA120.014630","article-title":"Modulating disease-relevant tau oligomeric strains by small molecules","volume":"295","author":"Lo Cascio","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.molstruc.2022.133574_bib0023","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/anie.200802621","article-title":"Development of tau aggregation inhibitors for Alzheimer's disease","volume":"48","author":"Bulic","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"7","key":"10.1016\/j.molstruc.2022.133574_bib0024","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.molstruc.2022.133574_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12035-018-1102-0","article-title":"First-in-rat study of human Alzheimer's disease tau propagation","volume":"56","author":"Smolek","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.molstruc.2022.133574_bib0026","first-page":"1381","article-title":"Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains","volume":"9","author":"Himmler","year":"1989","journal-title":"Mol. Cell Biol."},{"issue":"32","key":"10.1016\/j.molstruc.2022.133574_bib0027","doi-asserted-by":"crossref","first-page":"24977","DOI":"10.1074\/jbc.M000808200","article-title":"Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly","volume":"275","author":"Evans","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2-3","key":"10.1016\/j.molstruc.2022.133574_bib0028","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0014-5793(99)00222-7","article-title":"Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation","volume":"446","author":"Dayanandan","year":"1999","journal-title":"FEBS Lett."},{"issue":"2-3","key":"10.1016\/j.molstruc.2022.133574_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molstruc.2022.133574_bib0030","doi-asserted-by":"crossref","first-page":"131569","DOI":"10.1016\/j.molstruc.2021.131569","article-title":"In vitro characterization of urea derivatives to inhibit alpha-synuclein early-stage aggregation","volume":"1249","author":"Soham","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.molstruc.2022.133574_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1139\/cjpp-2015-0204","article-title":"Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide fibrillization and cytotoxicity","volume":"94","author":"Fortin","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"13","key":"10.1016\/j.molstruc.2022.133574_bib0032","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-03-3715","article-title":"Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance","volume":"64","author":"Petitclerc","year":"2004","journal-title":"Cancer Res,"},{"issue":"2","key":"10.1016\/j.molstruc.2022.133574_bib0033","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/jpet.106.110957","article-title":"Microtubule-destabilizing agents induce focal adhesion structure disorganization and anoikis in cancer cells","volume":"320","author":"Deschesnes","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.molstruc.2022.133574_bib0034","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.molstruc.2022.133574_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Gade Malmos","year":"2017","journal-title":"Amyloid"},{"issue":"41","key":"10.1016\/j.molstruc.2022.133574_bib0036","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.molstruc.2022.133574_bib0037","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.3390\/ijms21155193","article-title":"Rapid alpha-synuclein toxicity in a neural cell model and its rescue by a stearoyl-CoA desaturase inhibitor","volume":"21","author":"Terry-Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.molstruc.2022.133574_bib0038","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: history of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.molstruc.2022.133574_bib0039","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jphotobiol.2018.10.007","article-title":"Cationic red emitting fluorophore: a light up NIR fluorescent probe for G4-DNA","volume":"190","author":"Kumari","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"issue":"16","key":"10.1016\/j.molstruc.2022.133574_bib0040","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.molstruc.2022.133574_bib0041","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2013.07.022","article-title":"Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data","volume":"68","author":"Artese","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt A","key":"10.1016\/j.molstruc.2022.133574_bib0042","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ijbiomac.2018.08.175","article-title":"Effective suppression of the modified PHF6 peptide\/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: another evidence for the pigment as preventive\/therapeutic \u201cfunctional food","volume":"120","author":"Bijari","year":"2018","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286022012303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286022012303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:34:58Z","timestamp":1777419298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286022012303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"alternative-id":["S0022286022012303"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2022.133574","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-fibrillization effects of sulfonamide derivatives on \u03b1-synuclein and hyperphosphorylated tau isoform 1N4R","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2022.133574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"133574"}}